MiNK Therapeutics, Inc.·4

Sep 11, 4:05 PM ET

Corvese Brian 4

4 · MiNK Therapeutics, Inc. · Filed Sep 11, 2025

Insider Transaction Report

Form 4
Period: 2025-09-09
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-09-09+3,2253,225 total
    Exercise: $15.36Exp: 2035-09-09Common Stock (3,225 underlying)
Footnotes (1)
  • [F1]The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4